🇺🇸 ALATROFLOXACIN MESYLATE in United States

FDA authorised ALATROFLOXACIN MESYLATE on 18 December 1997

Marketing authorisations

FDA — authorised 18 December 1997

  • Application: NDA020760
  • Marketing authorisation holder: PFIZER
  • Local brand name: TROVAN PRESERVATIVE FREE
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA

  • Status: approved

ALATROFLOXACIN MESYLATE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is ALATROFLOXACIN MESYLATE approved in United States?

Yes. FDA authorised it on 18 December 1997; FDA has authorised it.

Who is the marketing authorisation holder for ALATROFLOXACIN MESYLATE in United States?

PFIZER holds the US marketing authorisation.